Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Ecolab Inc. ofrece soluciones y servicios de agua, higiene y prevención de infecciones en los Estados Unidos e internacionalmente. La empresa opera a través de cuatro segmentos: agua global, instituciones y especialidades globales, eliminación global de plagas y ciencias biológicas globales.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $16.8B | $16.1B | $15.7B | $15.3B | $14.2B | $12.7B | $11.8B | $12.6B | $14.7B | $13.8B | $13.2B | $13.5B | $14.3B | $13.3B | $11.8B | $6.8B | $6.1B | $5.9B | $6.1B | $5.5B | $4.9B |
| Beneficio bruto | $7.4B | $7.2B | $6.8B | $6.2B | $5.4B | $5.2B | $4.9B | $5.5B | $6.1B | $5.8B | $6.3B | $6.4B | $6.6B | $6.1B | $5.4B | $3.4B | $3.1B | $2.9B | $3.0B | $2.8B | $2.5B |
| % de margen bruto | 44.1% | 44.5% | 43.5% | 40.3% | 38.2% | 41.0% | 41.5% | 44.0% | 41.3% | 42.1% | 47.9% | 47.0% | 46.3% | 45.7% | 46.0% | 49.3% | 50.6% | 49.6% | 48.8% | 50.8% | 50.6% |
| Ingresos operativos (EBIT) | $2.9B | $2.9B | $2.6B | $2.2B | $1.6B | $1.7B | $1.7B | $1.9B | $2.0B | $2.2B | $2.0B | $2.0B | $2.0B | $1.8B | $1.5B | $928M | $823M | $750M | $738M | $687M | $612M |
| % de margen operativo | 17.4% | 18.1% | 16.6% | 14.1% | 11.3% | 13.2% | 14.5% | 15.2% | 13.5% | 15.9% | 15.3% | 14.6% | 14.2% | 13.4% | 12.9% | 13.6% | 13.5% | 12.7% | 12.0% | 12.6% | 12.5% |
| Ingresos netos | $2.1B | $2.1B | $2.1B | $1.4B | $1.1B | $1.1B | ($1.2B) | $1.6B | $1.4B | $1.5B | $1.2B | $1.0B | $1.2B | $968M | $704M | $462M | $530M | $417M | $448M | $427M | $369M |
| % de margen neto | 12.6% | 12.9% | 13.4% | 9.0% | 7.7% | 8.9% | -10.2% | 12.4% | 9.7% | 10.9% | 9.3% | 7.4% | 8.4% | 7.3% | 5.9% | 6.8% | 8.7% | 7.1% | 7.3% | 7.8% | 7.5% |
| EBITDA | $3.3B | $3.5B | $3.8B | $3.0B | $2.5B | $2.5B | $2.2B | $2.7B | $3.0B | $2.9B | $2.8B | $2.4B | $2.8B | $2.4B | $2.0B | $1.1B | $1.2B | $1.0B | $1.1B | $965M | $887M |
| Beneficio por acción (EPS) | $7.45 | $7.28 | $7.37 | $4.79 | $3.81 | $3.91 | $-4.20 | $5.33 | $4.88 | $5.12 | $4.14 | $3.32 | $3.93 | $3.16 | $2.35 | $1.91 | $2.23 | $1.74 | $1.80 | $1.70 | $1.43 |
| Acciones en circulación (M) | 283M | 285M | 287M | 286M | 287M | 289M | 287M | 292M | 293M | 294M | 297M | 301M | 306M | 306M | 299M | 242M | 238M | 240M | 249M | 252M | 257M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de ECL. /companies/us/ECL
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms